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Metacognitions about the positive and negative effects of smoking have been 
associated with cigarette use and nicotine dependence. The aim of the present study was to 
validate the Turkish version of the Metacognitions about Smoking Questionnaire (MSQ; 
Nikčević et al., 2015). The sample consisted of 859 self-declared smokers (452 female) aged 
between 18 and 68 years (mean = 28.3; SD = 7.9). Once the English to Turkish translation of 
the MDQ was completed, confirmatory factor analyses were conducted based on the four-
factor structure of the original measure. Initially results suggested that this model was an 
inadequate fit of the data obtained. However, by allowing three pairs of items (within factor) 
to co-vary, a re-specified model was tested that was found to be a satisfactory fit of the data. 
Internal reliability and predictive validity of the translated scale were observed to be good. 
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The Turkish version of the MSQ exhibited suitable psychometric properties. This study also 
showed that metacognitions about smoking predict nicotine dependence independently of 
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 The metacognitive model of psychopathology developed by Wells and Matthews 
(1994; 1996) advocates that the escalation and persistence of psychological distress is linked 
to the presence of metacognitions. Metacognitions refer to the beliefs we hold about our 
cognitive system and ways that we can control it (Wells, 2000). They can be broadly 
separated into two domains: (1) positive metacognitions about control strategies that impact 
on inner events (e.g., “Worry will help me problem-solve” or “If I ruminate I will remember 
more accurately”); and (2) negative metacognitions concerning the significance, 
controllability, and danger of inner events (e.g., “Having certain thoughts means I am weak” 
or “I cannot stop worrying”). 
 According to the metacognitive model, the selection and implementation of coping 
strategies for controlling cognition is partially determined by positive metacognitions that 
paradoxically focus attention towards distress congruent information (e.g., environmental 
threats, negative affect, and symptoms/bodily sensations). This leads to the activation of 
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unhelpful coping strategies (e.g., avoidance, thought suppression, and perseverative thinking) 
that fail to result in a successful psychological resolution. Over time, the engagement in these 
maladaptive coping strategies leads to the development of an internal dissonance 
characterized by negative metacognitions towards the selected coping strategies and internal 
experiences more generally leading to the escalation of psychological distress. Research 
spanning almost thirty years has found that metacognitions are associated with, and are an 
important independent explanatory variable for, a wide array of psychological and 
behavioural problems (for a review see Wells, 2013). This includes addictive behaviours such 
as alcohol use (e.g., Clark et al., 2012; Spada et al., 2009; Spada & Wells, 2005; 2006; 2008; 
2009; 2010), gambling (e.g. Lindberg et al., 2011; Spada et al., 2014), and problematic 
Internet use (Spada et al., 2008). 
Five key studies have been undertaken that have investigated the role of 
metacognitions in nicotine use. In the earliest study, Spada and colleagues (Spada et al., 
2007) employed a generic measure of maladaptive metacognitions (the Metacognitions 
Questionnaire 30; Wells & Cartwright-Hatton, 2004) and found evidence that positive beliefs 
about worry, lack of cognitive confidence, and beliefs about the need to control thoughts 
were significantly associated with nicotine use, independently of negative emotions. The 
authors proposed that positive beliefs about worry and beliefs about cognitive confidence 
represent metacognitive knowledge about a diminished confidence in coping, as well as a 
need to anticipate problems and to control cognition. They argued that these metacognitions 
would contribute to nicotine dependence because smoking enhances subjective cognitive 
confidence: in the short-term some believe that smoking can result in improvements in 
vigilance, rapid information processing, and verbal recall. The authors also reflected that 
beliefs about the need to control thoughts could be a marker for attitudes towards intrusive 
thoughts, such as ‘craving’ thoughts about smoking. In other words, such thoughts need to be 
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controlled otherwise they will ‘take-over’ an individual’s behaviour and they may not be able 
to stop thinking about smoking. 
 In a second study, Nikčević and Spada (2008) investigated the role of 
metacognitions in high-dependency smokers, low-dependency smokers, and non-smokers 
using the MCQ-30. They found that high-dependency smokers scored higher than non-
smokers on positive beliefs about worry. Furthermore, they observed that, on beliefs about 
the need to control thoughts, high and low-dependency smokers scored higher than non-
smokers. The results were in line with Spada and colleagues’ earlier findings (Spada et al., 
2007), providing further evidence that generic metacognitions play a role in nicotine 
dependence. 
In view of the findings from the above studies, Nikčević and Spada (2010) undertook 
a qualitative study involving 12 smokers aimed at investigating whether specific types of 
metacognitions played a role in explaining smoking initiation and perseveration. Results 
indicated that participants endorsed both positive and negative metacognitions about 
smoking. Positive metacognitions reflected the usefulness of smoking in the regulation of 
emotional and cognitive states. Negative metacognitions concerned the uncontrollability of 
‘smoking urges’ and the negative impact of smoking on self-appraisal. A fourth study 
undertaken by Nosen and Woody (2014) recruited 176 adult smokers interested in quitting 
and found that smoking cessation outcomes and metacognitions were likely to have a 
bidirectional relationship that is strongly related to negative affect. 
Following on from these findings, and especially those obtained from Nikčević and 
Spada’s (2010) interviews, Nikčević and colleagues (Nikčević et al., 2015) developed the 
Metacognitions about Smoking Questionnaire (MSQ). Exploratory and confirmatory factor 
analyses supported a four-factor solution for the MSQ with the following factors: positive 
metacognitions about cognitive regulation, positive metacognitions about emotional 
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regulation, negative metacognitions about uncontrollability, and negative metacognitions 
about cognitive interference. The MSQ was shown to possess convergent and predictive 
validity, adequate-to-good internal consistency, and temporal stability. 
The aim of the current study was to translate the original English version of the MSQ 
into Turkish and to examine its psychometric properties in a large sample of smokers. The 
translated MSQ may be of use not only because Turkish is a language spoken by almost by 
220 million people around the world (Akalın, 2009), but also because smoking is a 
considerable health problem in Turkey. Indeed almost 27% of the Turkish population over 
the age of 15 consumes tobacco products (World Health Organization, 2015), even after 
reductions brought about by legal restrictions on smoking (Jakab et al., 2014). In addition, 
approximately 100,000 individuals die yearly of smoking-related diseases in Turkey (Bilici, 
2012). 
We first ran a series of confirmatory factor analyses of a Turkish version of the MSQ. 
We then investigated its internal consistency and concurrent validity. When examining 
concurrent validity, we wanted to examine whether factors of the MSQ would be 
significantly associated with nicotine dependence when controlling for age, gender, negative 
affect, the age an individual started smoking, exposure to smoking cessation treatment, and 
smoking outcome expectancies. 
We chose to control for smoking outcome expectancies because they are a related but 
separate construct from metacognitions about smoking. As postulated by Nikčević and 
colleagues (2015), there is an overlap between metacognitions about smoking and smoking 
outcome expectancies. Arguably the positive dimensions of both constructs capture what are 
essentially motivations for smoking. However, we argue that a nuanced but crucial difference 
exists between them, even in their ‘positive’ iterations: i.e., positive smoking outcome 
expectancies do not explicitly distinguish between cognitive and metacognitive belief 
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domains. Furthermore, whereas negative smoking outcome expectancies mainly measure 
general negative outcomes arising from smoking, negative metacognitions about smoking tap 
into the perception of lack of executive control and presumed cognitive interference that 
result from smoking and perseverative smoking-related thoughts. 
From a metacognitive standpoint, high scores on negative metacognitions about 
smoking are the key marker of the perseveration of psychopathology because they may play a 
role in propagating negative affect, preventing the discontinuation of maladaptive coping 
behaviour (Nosen and Woody, 2014; Wells, 2009). Such differences between smoking 
outcome expectancies and metacognitions are important because (according to the 
burgeoning evidence that has supported the metacognitive model of psychopathology) the 
key beliefs of psychopathology are metacognitive rather than cognitive (Wells, 2009). Thus, 
in this study, we have hypothesized that metacognitions about smoking would be 




The sample consisted of 859 self-declared Turkish smokers (452 female) aged 
between 18 and 68 years (mean = 28.3; SD = 7.9). The smoking behaviour characteristics of 
the sample varied widely, with some reporting that they did not smoke daily and others 
declaring that they smoked up to 75 cigarettes a day (mode = 20). Most participants stated 
that they started smoking by the age 20, though this ranged from six years of age to 37. With 
respect to smoking cessation, only 5.1% of the sample reported that they had engaged in 
treatment to stop smoking. 
Just over half the participants were currently employed (55.5%) and most perceived 
their socio-economic status to be at least ‘moderate’ (84.3%). Participants tended to live in 
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metropolitan areas of Turkey (84.7%), whilst fewer inhabited urban (12.5%) and rural 
regions (2.8%). Nearly all participants had been taught at high educational levels: 813 
(94.6%) were either current or former higher education students (i.e., associate, bachelor, 
graduate, or PhD degree levels). In terms of relationship status, most participants were single 
(75.5%) or married (22.0%). 
2.2 Materials 
The Turkish Metacognitions about Smoking Questionnaire (MSQ) was translated 
from the original 20-item English language version (Nikčević et al., 2015) for this study. The 
original MSQ consisted of four-factors each comprising of five-items that were designed to 
measure metacognitions specifically pertaining to smoking. The factors were labelled 
‘Positive Metacognitions about Cognitive Regulation’ (PM-CR), ‘Positive Metacognitions 
about Emotional Regulation’ (PM-ER), ‘Negative Metacognitions about Uncontrollability’ 
(NM-U), and ‘Negative Metacognitions about Cognitive Interference’ (NM-CI). 
Endorsement of the metacognitions was indicated on a four-point Likert-type scale. The 
English version of the MSQ has been shown to possess convergent and predictive validity, 
adequate-to-good internal consistency, and temporal stability (Nikčević et al., 2015). 
To measure nicotine dependency, we used the Turkish version of the Fagerstrom Test 
for Nicotine Dependence (FTND: Uysal et al., 2004). The original English version of the 
measure consisted of six items that contributed to a single factor and was designed to 
measure dependency on nicotine (Heatherton et al., 1991). The Turkish FTND can be scored 
according to a two-factor structure but item responses can be summed to calculate a total 
measure of nicotine dependence (Uysal et al., 2004). However, responses to the third item on 
the Turkish version were found not to significantly correlate with the total score, indicating 
that the translated version of this item might be poorly understood (Uysal et al., 2004). 
Additionally, removing the third item has been shown to increase the measure’s internal 
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consistency from 0.56 to 0.61 (Uysal et al., 2004). For these reasons, and because we were 
interested in a relative (and not an absolute) measure of nicotine dependence, we decided to 
omit this item from all statistical analyses, meaning that FTND total scores reported in this 
paper are based on five and not six items. The translated FTND has been reported to possess 
good test-retest reliability (Uysal et al., 2004). 
Additionally, we used the Turkish version of the 14-item Hospital Anxiety and 
Depression Scale (HADS), which has been shown to possess good psychometric properties 
(Aydemir, 1997), to control for levels of anxiety and depression. To control for beliefs that 
pertain to anticipated reinforcement and punishment of smoking, we used the Turkish version 
of the Brief Smoking Consequences Questionnaire for Adults (BSCQ; Süsen and Yalçınkaya-
Alkar, 2016). The BSCQ consists of 25-items that describe 10 factors, labelled: (1) ‘negative 
affect reduction’, (2) ‘stimulation state enhancement’, (3) ‘health risks’, (4) ‘taste and sensory 
motor manipulation’, (5) ‘social facilitation’, (6) ‘weight control’, (7) ‘craving addiction’, (8) 
‘negative physical feelings, (9) ‘boredom reduction’, and (10) ‘negative social impression’. 
Respondents indicate their strength of their endorsement of the beliefs described by the items 
using a 10-point Likert-type format. The Turkish BSCQ has been reported to possess good 
psychometric properties (Süsen and Yalçınkaya-Alkar, 2016). 
2.3 Procedure 
Ethical permission for the current study was approved from Dokuz Eylul University’s 
Literature Faculty’s Ethical Review Board. Then the MSQ (Nikčević et al., 2015) was 
translated into Turkish by a psychologist proficient in both English and Turkish. Following 
this, translated items were sent to six evaluators, all possessing doctoral degree qualifications 
in clinical and health psychology, to verify the content of the translated items. Once 
consensus had been achieved on the wording of items the Turkish version of MSQ was back-
translated by a linguist. Finally, eight smokers ranked the item comprehensibility of the 
RUNNING HEAD: MSQ in a Turkish sample 9 
Turkish version of the MSQ using 5 point Likert scale (from ‘Totally clear’ to ‘Totally 
unclear’) and offered some alternatives to item presentation when the item was assessed as 
unclear. Items of Turkish version of the MSQ were finalised with minor changes aided by 
this feedback process. 
The study was administered through unrestricted self-selected survey sampling by 
using web-survey methods. Dokuz Eylul University staff were alerted about the study by 
email and social media (e.g., Facebook and Twitter) and invited to take part using the Google 
Docs service. The identity of participants remained confidential and all participants could 
withdraw from the study at any time if the so wished. The web-survey was constructed such 
that participants had to answer all items before they could submit data. This meant there was 
no missing data. 
2.4 Data analysis 
Using Mplus version 6.0 (Muthén & Muthén, 2010), we tested the fit of the translated 
measure using the four-factor structure of the original English-version MSQ. We used 
Mahalanobis distances to identify outliers from the MSQ data. We choose a conservative 
alpha of 0.001 and Bonferroni’s correction to calculate a corrected alpha of 0.0000016 to 
identify outliers. This lead us to omitting nine observations, leaving a sample size of 850. We 
evaluated the data obtained from 20 translated items of the MSQ for deviations from 
univariate and multivariate normal distribution. The result of these analyses determined the 
method of estimation used in the subsequent confirmatory factor analyses. Modification 
indices, regression weights, factor loadings, and theory-driven considerations were employed 
to amend the initial model to improve fit. To assess gender invariance, the final model was 
fitted using data from males and females separately. 
Once a final model for the translated MSQ had been selected, we conducted a series 
of analyses using SPSS version 24 (IBM, 2017). The distribution of data from all 
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experimental measures (consisting of both their total scores and subscales) were examined 
for non-normality. These findings were used to determine the choice of parametric and/or 
nonparametric difference tests and correlation analyses that were used to test whether the 
translated scale possessed concurrent validity. 
Also, using SPSS version 24 (IBM, 2017), a hierarchical regression analysis was 
conducted using the FTND as the outcome variable. Variables that had been found in the 
earlier analyses to have a significant relationship with the FTND were used as independent 
variables to further examine the concurrent validity of the translated scale. The hierarchical 
regression model was examined for multicollinearity (through examining correlations and 
Variance Inflation Factors), the distribution of residuals (by generating histograms and 
normality plots), linearity and homoscedasticity (with plots of the regression-standardized 
residuals against the regression standardized predicted values), and the independence of 
errors (by conducting Durbin-Watson tests). 
3. Results 
3.1 Confirmatory factor analyses and internal reliability 
The data obtained from responses to individual items from the translated MSQ were 
treated as categorical-ordered and found to be absent of univariate and multivariate normality 
according to Mardia’s tests of skewness and kurtosis (multivariate CR = 51.22). A series of 
confirmatory factor analyses (CFA) were conducted on the data using Robust Weighted Least 
Squares (Means and Variances adjusted) as the estimator to test whether the four-factor 
structure of the English-version of the MSQ was appropriate for the translated measure. PM-
CR, PM-ER, NM-U, and NM-CI were defined as latent, continuous variables and, mirroring 
the structure of the original version, and the model proposed that each had five items 
observed categorical-ordered indicators. The model specified that the latent variables were 
correlated, mirroring the relationship between factors described in the study that developed 
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the original MSQ (Nikčević et al., 2015). Absolute (i.e., the root mean square error of 
approximation [RMSEA]) and incremental (i.e., the comparative fit index [CFI] and the 
Tucker-Lewis index [TLI; also, known as the non-normed fit index]) indices were calculated 
to evaluate model fit. An adequate fit is indicated by threshold values of equal to or less than 
0.08 for the RMSEA (Browne et al., 1993), and close to or above 0.95 for the CFI and TLI 




Table 1: Model fit indices 
 RMSEA CFI TLI 
Model 1 0.087 0.97 0.97 
Model 2 0.067 0.98 0.98 
Note. RMSEA= Root mean square error of approximation; CFI = comparative fit index; TFI = Tucker-Lewis 
index; n = 850. 
 
The initial model (Model 1) was judged as being an unsatisfactory fit of the data (see 
Table 1). The model was re-specified following consideration of modification indices, 
regression weights, factor loadings, and theory. Three pairs of indicator items of the MSQ (4 
and 8, 3 and 11, and 3 and 15) were allowed to co-vary because each pair loaded on a shared 
factor. We thought this to be theoretically justified because indicator items might share a 
degree of measurement error when trying to assess the same latent concept. This lead to a 
model that retained the same number of items and the same structure as the English version 
of the MSQ, which was an acceptable fit of the data (Model 2). These items were also used to 
generate a Scree plot that provided further support for the four-factor solution, with these 
factors explaining 72.3% of the total variance. To assess for configural gender invariance, we 
ran Model 2 twice, first with males only then females. The resulting CFIs, TLIs, and 
RMSEAs suggested that there was little configural variance in the proposed structure of the 
RUNNING HEAD: MSQ in a Turkish sample 12 
MSQ between genders (males: CFI = 0.99; TLI = 0.98; RMSEA = 0.064; females: CFI = 
0.98; TLI = 0.98; RMSEA = 0.062). Cronbach's alpha coefficients were calculated for each 
of the four factors of the translated MSQ, which resulted in values of 0.93 for PM-CR, 0.91 
for PM-ER, 0.84 for NM-CI, and 0.84 for NM-U, suggesting good internal reliability. Further 
calculations revealed that the internal reliability of the scale would not be significantly 
improved by removing any of the items. 
3.2 Descriptive statistics, normality tests, difference tests and FTND internal reliability 
Table 2 presents the means, standard deviations, and ranges of continuous variables 
generated by the measures used in this study. Kolmogorov-Smirnov tests suggested that the 
distribution of all the measures’ data was significantly different than normal and, 
consequently, Spearman’s rho correlations were generated to investigate the relationships 
between the study variables (see Table 2). Significant, positive correlations were found 
between all four factors of the MSQ and the FTND, age, HADS-A, and HADS-D. Significant 
relationships between SSA and both positive and negative metacognitions were also found, 
although in opposite directions (i.e., the former negatively and the latter positively 
associated). 
Mann-Whitney U differences tests were conducted using FTND as the dependent 
variable. Significant differences were found between gender (mean: male = 3.51 and female 
= 2.90; Mann Whitney U = 78157.5, n1[male] = 402; n2[female] = 448; p = 0.01) and whether 
participants had received smoking cessation treatment (mean: yes = 4.34 and no = 3.12; 
Mann Whitney U = 13069.5, n1[yes] = 44; n2[no] = 806; p = 0.003). We calculated further 
Mann-Whitney U tests using the four sub-factors of the MSQ as dependent variables and 
gender as the independent. Females scored significantly higher than males on PM-ER 
(means: male = 13.18 and female = 14.15; Mann Whitney U = 77827.5, n1[male] = 402; 
n2[female] = 448; p = 0.01), whilst the reverse was found on NM-CI (means: male = 13.18 
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and female = 14.15; Mann Whitney U = 81593.0, n1[male] = 402; n2[female] = 448; p = 
0.02). No gender difference was found using PM-CR and NM-U dependent variables. 
An earlier study had found the six-item version of the Turkish FTND problematic, 
suggesting the five-item version that has been employed in this study (Uysal et al., 2004). We 
wished to further establish some of the psychometric properties of the revised measure. We 
found that the five-item Turkish FTND had a higher internal consistency (with a Cronbach’s 
alpha of 0.71) than had been reported previously (Uysal et al., 2004). 
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Table 2: Means, SD, ranges, and Spearman’s correlation matrix for study variables 
Notes. FTND = Fagerstrom Test of Nicotine Dependence; SSA = started smoking age; HADS-A = Hospital Anxiety and Depression Scale – Anxiety; HADS-D = Hospital Anxiety and 
Depression Scale – Depression;  BSCQ = Brief Smoking Consequences Questionnaire – Adult (-1 = negative affect reduction; -2 = stimulation state enhancement; -3 = health risks; -4 = taste 
and sensory motor manipulation; -5 = social facilitation; -6 = weight control; -7 = craving addiction; -8 = negative physical feelings; -9 = boredom reduction; -10 = negative social impression); 
PM-CR = Positive Metacognitions about Cognitive Regulation; PM-ER = Positive Metacognitions about Emotional Regulation;  NM-CI = Negative Metacognitions about Cognitive 
Interference; NM-U = Negative Metacognitions about Uncontrollability; n = 850; * p<.05; **p<.01. 
Variable X SD Range 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1. FTND 3.19 2.47 0-9                                     
2. Age 28.31 7.90 17-68 0.11**                                   
3. SSA 18.63 3.40 6-37 -0.21** 0.19**                                 
4. HADS-A 9.26 4.20 0-20 0.12** -0.20** -0.12**                               
5. HADS-D 6.80 4.02 0-21 0.19** -0.12** -0.08* 0.62**                             
6. BSCQ-1 18.62 6.88 0-27 0.17** -0.09** -0.10** 0.18** 0.14**                           
7. BSCQ-2 6.69 4.97 0-18 0.17** -0.06 -0.08* 0.12** 0.04 0.43**                         
8. BSCQ-3 15.78 3.46 0-18 0.05 0.09** 0.01 0.00 -0.01 0.10** -0.12**                       
9. BSCQ-4 12.08 8.04 0-27 0.21** -0.03 -0.18** 0.00 -0.02 0.27** 0.36** -0.10**                     
10. BSCQ-5 11.94 7.21 0-27 0.13** -0.19** -0.06 0.23** 0.18** 0.38** 0.33** -0.05 0.22**                   
11. BSCQ-6 9.35 8.24 0-27 0.13** 0.03 -0.05 0.13** 0.08* 0.20** 0.28** 0.03 0.18** 0.27**                 
12. BSCQ-7 10.88 5.51 0-18 0.39** 0.04 -0.19** 0.16** 0.14** 0.40** 0.22** 0.16** 0.17** 0.23** 0.23**               
13. BSCQ-8 9.25 4.87 0-18 0.00 -0.01 0.14** 0.14** 0.14** 0.03 -0.09* 0.24** -0.25** 0.06 0.08* 0.16**             
14. BSCQ-9 12.96 4.82 0-18 0.25** -0.18** -0.13** 0.19** 0.16** 0.42** 0.29** 0.16** 0.14** 0.34** 0.15** 0.37** 0.11**           
15. BSCQ-10 9.53 6.42 0-27 0.05 0.03 0.07* 0.13** 0.15** 0.03 0.04 0.16** -0.18** 0.15** 0.25** 0.15** 0.33** 0.09**         
16. PM-CR 10.77 4.43 5-20 0.28** -0.11** -0.16** 0.16** 0.12** 0.55** 0.47** -0.06 0.31** 0.36** 0.26** 0.34** -0.09** 0.30** 0.00       
17. PM-ER 13.68 4.14 5-20 0.17** -0.18** -0.10** 0.19** 0.16** 0.79** 0.38** 0.05 0.27** 0.36** 0.20** 0.31** -0.01 0.36** -0.02 0.68**     
18. NM-CI 8.49 3.67 5-20 0.42** 0.13** -0.10** 0.27** 0.27** 0.20** 0.09* 0.22** 0.03 0.25** 0.22** 0.44** 0.20** 0.28** 0.34** 0.23** 0.22**   
19. NM-U 10.27 4.05 5-20 0.42** 0.10** -0.12** 0.23** 0.23** 0.22** 0.07* 0.26** -0.02 0.21** 0.19** 0.43** 0.21** 0.30** 0.31** 0.24** 0.25** 0.79** 
RUNNING HEAD: MSQ in a Turkish sample 15 
3.3 Concurrent validity 
To evaluate the concurrent validity of the new translated MSQ, we conducted a five-step 
hierarchical regression analysis with nicotine dependence (FTND) as the outcome and the 
variables found to have a significantly impact on it in the correlation analyses entered as 
independent variables. In the first step demographic variables were force-entered into the 
model (i.e., gender and age) and negative affect on the second. Smoking characteristic (i.e., 
the age that participants started to smoke and whether treatments for smoking cessation had 
been attempted) were entered on the third. On the fourth step, the previously identified 
smoking consequences factors that had been found to be significantly associated with FTND 
were added to the model, before all MSQ factors were entered on the fifth and final step (see 
Table 3). 
 When conducting the regression analyses, we also tested the model’s data in respect 
to relevant statistical assumptions. Firstly, there was no evidence of multicollinearity: (1) no 
correlations equal or greater than .9 between the predictor variables was found and (2) all 
Variance Inflation Factors were well below 10. Secondly, histograms and normality plots 
suggested that the residuals were normally distributed. Thirdly, plots of the regression-
standardized residuals against the regression standardized predicted values suggested that the 
assumptions of linearity and homoscedasticity were met and, fourthly, Durbin-Watson tests 
suggested that the data did not violate the assumption of independent errors.  
 In the final step of the model, age, as well as the age the participant started smoking, 
levels of anxiety and depression, three factors from the BSCQ (i.e., ‘negative affect 
reduction’, ‘stimulation state enhancement’, and ‘boredom reduction’), and three factors of 
the Turkish version of the MSQ were significantly associated with FTND. The PM-ER factor 
was not significantly associated with FTND in this analysis. This final model accounted for 
33% of the variance of nicotine dependence. 





Table 3: Hierarchical regression with FTND as the outcome variable 
 
      95% Confidence 
Interval 
Predictor R2 Adjusted R2 R2  Change B SE Βeta LL UL 
Step 1         
 Gender    -0.59** 0.17 -0.12 -0.92 -0.26 
 Age     0.03* 0.01 0.09 0.01 0.05 
  0.02** 0.02 0.02**          
Step 2         
 Gender    -0.57** 0.17 -0.12 -0.90 -0.24 
 Age    0.04** 0.01 0.11 0.02 0.06 
 HADS-A    0.03 0.03 0.06 -0.02 0.08 
 HADS-D     0.10** 0.03 0.16 0.05 0.15 
  0.06** 0.06 0.04**          
Step 3         
 Gender    -0.42* 0.16 -0.09 -0.74 -0.10 
 Age    0.04** 0.01 0.14 0.02 0.06 
 HADS-A    0.02 0.02 0.03 -0.03 0.06 
 HADS-D    0.10** 0.03 0.17 0.05 0.15 






 0.83* 0.37 0.07 0.11 1.55 
   0.12** 0.11 0.05**          
Step 4         
 Gender    -0.46** 0.15 -0.09 -0.77 -0.16 
 Age    0.04** 0.01 0.14 0.02 0.06 
 HADS-A    -0.01 0.02 -0.01 -0.05 0.04 
 HADS-D    0.09** 0.02 0.15 0.04 0.14 






 0.61 0.34 0.06 -0.06 1.29 
 BSCQ-1    -0.05 0.03 -0.05 -0.11 0.01 
 BSCQ-2    0.23** 0.03 0.27 0.17 0.28 
 BSCQ-4    -0.01 0.04 -0.01 -0.10 0.08 
 BSCQ-5    0.06 0.04 0.06 -0.03 0.14 
 BSCQ-6    -0.04 0.04 -0.04 -0.11 0.03 
 BSCQ-7    0.04 0.04 0.05 -0.04 0.11 
 BSCQ-9     0.14** 0.04 0.16 0.07 0.22 
  0.24** 0.23 0.12**          
Step 5         
 Gender    -0.24 0.15 -0.05 -0.53 0.05 
 Age    0.02* 0.01 0.08 0.01 0.04 
 HADS-A    -0.04* 0.02 -0.07 -0.09 0.00 
 HADS-D    0.08** 0.02 0.12 0.03 0.12 






 0.30 0.32 0.03 -0.34 0.93 
 BSCQ-1    -0.07* 0.03 -0.07 -0.13 -0.01 
 BSCQ-2    0.13** 0.03 0.15 0.07 0.18 
 BSCQ-4    -0.01 0.04 -0.01 -0.10 0.07 
 BSCQ-5    0.04 0.04 0.04 -0.04 0.12 
 BSCQ-6    -0.04 0.05 -0.04 -0.13 0.05 
 BSCQ-7    0.02 0.04 0.03 -0.05 0.10 
 BSCQ-9    0.08* 0.04 0.09 0.01 0.15 
 PM-CR    0.10** 0.02 0.18 0.06 0.15 





 PM-ER    -0.06 0.03 -0.10 -0.12 0.00 
 NM-CI    0.13** 0.03 0.20 0.07 0.19 
 NM-U    0.09** 0.03 0.15 0.04 0.15 
  0.33** 0.32  0.09**          
Notes. FTND = Fagerstrom Test of Nicotine Dependence; Gender code (0 = male; 1 = female); HADS-A = 
Hospital Anxiety and Depression Scale – Anxiety; HADS-D = Hospital Anxiety and Depression Scale – 
Depression; SSA = started smoking age; Smoking cessation treatment code (0 = yes, 1 = no); BSCQ = Brief 
Smoking Consequences Questionnaire – Adult (-1 = negative affect reduction; -2 = stimulation state 
enhancement; -4 = taste and sensory motor manipulation; -5 = social facilitation; -6 = weight control; -7 = 
craving addiction; -9 = boredom reduction); PM-CR = Positive Metacognitions about Cognitive Regulation; 
PM-ER = Positive Metacognitions about Emotional Regulation;  NM-CI = Negative Metacognitions about 
Cognitive Interference; NM-U = Negative Metacognitions about Uncontrollability; n = 850; * p<.05; **p<.01. 






The aim of the present study was to validate the Turkish version of the Metacognitions 
about Smoking Questionnaire (MSQ) developed by Nikčević and colleagues (2015) in a 
sample of 859 (reduced to 850 after removing outliers) self-declared smokers. A confirmatory 
factor analysis was conducted to test whether the four-factor structure of the English-version 
of the MSQ was appropriate for the translated measure. The original 20-item, four-factor 
model appeared to be an inadequate fit of the data obtained. Modification indices were thus 
calculated leading to a re-specified model that allowed three pairs of observed indicators to 
co-vary. This model was found to be a satisfactory fit of the data. Internal reliability and 
concurrent validity were observed to be good. Results also indicated that metacognitions 
about smoking (except for positive metacognitions about emotional regulation) predicted 
nicotine dependence over and above demographic variables, length of cigarette use, negative 
affect, and smoking outcome expectancies. 
Also of interest are the relationships between metacognitions and both a smoker’s age 
and how old they were when they started smoking. Our findings seem to suggest that younger 
individuals are significantly more likely to endorse stronger positive metacognitions about 
smoking than those older. Conversely, as people age, they appear significantly more likely to 
endorse stronger negative metacognitions about smoking. Could this reflect a ‘faux wisdom’ 
that people develop as they age? Despite stronger endorsement of negative metacognitions, 
possibly reflecting a greater awareness of the negative consequences of smoking, as smokers 
age they still smoke. Is the relationship between nicotine dependence and negative 
metacognitions characterised by the overlap between an awareness of the negative 
consequences of smoking and negative metacognitions about smoking, or does it help to 
differentiate these two constructs? Perhaps this can be answered using the framework of the 
metacognitive model of psychopathology. Perseveration is the key to understanding 





psychopathology from this perspective, and this is purportedly fuelled by negative 
metacognitions about uncontrollability (that are not directly assessed by the BSCQ). Also 
note that only positive smoking consequences were significant predictors of nicotine 
dependence in the final step of our regression model, which controlled for negative 
metacognitions and age. This supports further the distinction between negative 
metacognitions and smoking consequences, stressing the importance of the former over the 
latter in explaining nicotine dependence. 
Furthermore, our results suggest that the more recently someone starts smoking, the 
more likely they are to endorse both positive and negative metacognitions about smoking. 
This may allude to the following speculation: metacognitions tend to navigate a journey over 
time through consciousness along a dimension that begins at explicit awareness of these 
beliefs, heading towards implicit. In other words, people becoming less aware of their 
metacognitions the more time passes. 
In terms of gender difference, we found that males in our sample had higher levels of 
nicotine dependence and negative metacognitions about cognitive interference than females. 
Conversely, females endorsed higher positive metacognitions about emotional regulation than 
males. Despite these differences, gender was not a significant explanatory variable in the final 
step of our hierarchal regression analysis (with FTND as the outcome variable), nor did our 
results suggest that the structure of the translated MSQ is gender invariant. However, positive 
metacognitions about emotional regulation was not a significant independent variable in the 
final step of the hierarchal regression analysis, a step that also modelled gender. It is possible 
that the non-significance of PM-ER in explaining variance in nicotine dependence was a 
consequence of gender differences. 
These results demonstrate the utility of the Turkish version of the MSQ, confirming 
the potential role of metacognitions in sustaining smoking as well as their validity as a 





‘transcultural’ construct. The additional finding that metacognitions about smoking was 
significantly associated with smoking behaviour independently of smoking outcome 
expectancies reinforce the findings of Nikčević and colleagues (2015). These findings 
highlight the potential utility of employing techniques and principles of MCT (Wells, 2009), 
which have been found to be very effective in the treatment of anxiety and mood disorders 
(Normann et al., 2014), in aiding the discontinuation of smoking behaviour. The core 
techniques of which could be utilised to tackle problematic smoking behaviour, including the 
re-appraisal of both positive and negative metacognitions as well as interventions aimed at 
modifying metacognitive knowledge, such as detached mindfulness, attention training, 
situational attentional refocusing, and the postponement of use (Spada et al., 2015). 
It should be noted that the present results are preliminary in nature. A key limitation of 
this study, as well as earlier research that has explored the relationship between 
metacognitions and smoking, is the absence of longitudinal data which precludes causal 
inferences. In addition, the presence of concurrent psychological disorder (which could 
account for the observed differences in outcome measures) was not assessed. However, 
controlling for anxiety and depression does provide a degree of confidence in the specificity 
of the results. Finally, the temporal stability of the MSQ was not evaluated. 
Future studies are required to confirm the psychometric properties of the Turkish 
version of the MSQ. It would be necessary to determine the structure and reliability over time 
of this self-report questionnaire. In addition, studies are required to examine the sensitivity of 
the different factors of the MSQ to treatment effects and recovery if these are to prove useful 
as treatment evaluation markers. 
Acknowledgements 
Author BAF receives salary support from the National Institute for Health Research 
(NIHR) Mental Health Biomedical Research Centre and Dementia Research Unit at South 





London and Maudsley NHS Foundation Trust and King’s College London. The views 
expressed are those of the authors and not necessarily those of the NHS, the NIHR or the 
Department of Health. 






Akalın, Ş.H., 2009. Türk Dili: Dünya Dili. Türk Dili. 687, 195-204. 
Aydemir, Ö., 1997. Hastane Anksiyete ve Depresyon Ölçeği Türkçe formunun geçerlik ve 
güvenlik çalışması. Türk Psikiyatri Dergisi 8, 280-287. 
Bilici, M., 2012. Tütün (nikotin) kullanımına bağlı ruhsal ve davranışsal bozukluklar. Madde 
Bağımlılığı Tanı Ve Tedavi Kılavuzu El Kitabı. (pp. 187 – 196). T.C. Sağlık 
Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü, Ankara, Turkey. 
Browne, M.W., Cudeck, R., Bollen, K.A., Long, J.S., 1993. Alternative ways of assessing 
model fit. Sage Focus Editions 154, 136-136.  
Clark, A., Tran, C., Weiss, A., Caselli, G., Nikčević, A.V., Spada, M.M., 2012. The Big 5 
facets of personality and metacognitions as predictors of level of alcohol consumption 
in binge drinking university students. Addict. Behav. 37, 537-540 
Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerstrom, K.O., 1991. The Fagerstrom 
Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. 
Brit. J. Addict. 86, 1119-1127.  
Hu, L.T., Bentler, P.M., 1999. Cutoff criteria for fit indexes in covariance structure analysis: 
Conventional criteria versus new alternatives. Struct. Equ. Modeling 6, 1-55. 
IBM (2017). IBM SPSS Statistics: Version 24: IBM Corporation Chicago, IL. 
Jakab, M., Hawkins, L., Loring, B., Tello, J., Ergüder, T., ve Kontas, M., 2014. Better 
noncommunicable disease outcomes: Challenges and opportunities for health systems. 
World Health Organization Regional Office for Europe 2. 
Lindberg, A., Fernie, B.A., Spada, M. M., 2011. Metacognitions in problem gambling. J. 
Gambl. Stud. 27, 73-81. 
Muthén, L., & Muthén, B. (2010). Mplus software (version 6). Los Angeles, CA: Muthén & 
Muthén.  





Nikčević, A.V., Caselli, G., Wells, A., Spada, M.M., 2015. The metacognitions about 
smoking questionnaire: development and psychometric properties. Addict. Behav. 44, 
102-107. 
Nikčević, A.V., Spada, M. M., 2008. Metacognitions across the continuum of smoking 
dependence. Behav. Cogn. Psychoth. 36, 333-339. 
Nikčević, A.V., Spada, M.M., 2010. Metacognitions about smoking: a preliminary 
investigation. Clin. Psychol. Psychot. 17, 536-542. 
Normann, N., van Emmerik, A.A., Morina, N., 2014. The efficacy of metacognitive therapy 
for anxiety and depression: a meta-analytic review. Depress. Anxiety 31, 402-411. 
Nosen, E., Woody, S.R., 2014. Acceptance of cravings: how smoking cessation experiences 
affect craving beliefs. Behav. Res. Ther. 59, 71-81. 
Rosseel, Y., 2012. Lavaan: An R package for structural equation modeling. J. Stat. Softw. 48, 
1-36.  
Schermelleh-Engel, K., Moosbrugger, H., Müller, H., 2003. Evaluating the fit of structural 
equation models: Tests of significance and descriptive goodness-of-fit measures. 
Meth. Psych. Res. Onl. 8, 23-74.  
Spada, M.M., Caselli, G., Nikčević, A.V., Wells, A., 2015. Metacognition in addictive 
behaviors. Addict. Behav. 44, 9-15. 
Spada, M.M., Caselli, G., Wells, A., 2009. Metacognitions as a predictor of drinking status 
and level of alcohol use following CBT in problem drinkers: a prospective study. 
Behav. Res. Ther. 47, 882-886. 
Spada, M.M., Giustina, L., Rolandi, S., Fernie, B.A., Caselli, G., 2015. Profiling 
metacognition in gambling disorder. Behav. Cogn. Psychoth. 43, 614-622. 
Spada, M.M., Langston, B., Nikčević, A.V., Moneta, G.B., 2008. The role of metacognitions 
in problematic internet use. Comput. Hum. Behav. 24, 2325-2335. 





Spada, M.M., Nikčević, A.V., Moneta, G.B., Wells, A., 2007. Metacognition as a mediator of 
the relationship between emotion and smoking dependence. Addict. Behav. 32, 2120-
2129. 
Spada, M.M., Wells, A., 2005. Metacognitions, emotion and alcohol use. Clin. Psychol. 
Psychot. 12, 150-155. 
Spada, M.M., Wells, A., 2006. Metacognitions about alcohol use in problem drinkers. Clin. 
Psychol. Psychot. 13, 138-143. 
Spada, M.M., Wells, A., 2008. Metacognitive beliefs about alcohol use: development and 
validation of two self-report scales. Addict. Behav. 33, 515-527. 
Spada, M.M., Wells, A., 2009. A metacognitive model of problem drinking. Clin. Psychol. 
Psychot. 16, 383-393. 
Spada, M.M., Wells, A., 2010. Metacognitions across the continuum of drinking behaviour. 
Pers. Indiv. Differ. 49, 425-429. 
Süsen, Y., Yalçınkaya-Alkar, Ö., 2016. Predictors of Nicotine Dependence among Turkish 
Smokers. 46th European Association of Behavioural and Cognitive Therapies 
Congress. Stockholm, Sweden. 
Uysal, M.A., Kadakal, F., Karsidag, C., Bayram, N.G., Uysal, O., Yılmaz, V., 2004. 
Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor 
analysis. Tüberküloz ve Toraks Dergisi 52, 115-121. 
Wells, A., 2000. Emotional Disorders and Metacognition: Innovative Cognitive Therapy. 
Wiley, Chichester, UK. 
Wells, A., 2009. Metacognitive Therapy for Anxiety and Depression. Guilford Press, New 
York, USA. 
Wells, A., 2013. Advances in Metacognitive Therapy. Int. J. Cogn. Ther. 6, 186-201. 





Wells, A., Cartwright-Hatton, S., 2004. A short form of the metacognitions questionnaire: 
properties of the MCQ-30. Behav. Res. Ther. 42, 385-396. 
Wells, A., Matthews, G., 1994. Attention and Emotion: A Clinical Perspective. Lawrence 
Erlbaum Associates, Hove, UK. 
Wells, A., Matthews, G., 1996. Modelling cognition in emotional disorder: The S-REF 
model. Behav. Res. Ther. 34, 881-888. 
WHO Report on the Global Tobacco Epidemic, 2015. Country Profile: Turkey. World Health 
Organization. 





Appendix: Adapted version of Metacognitions about Smoking Questionnaire (MSQ) 
Sigara İçmeyle ilgili Üstbilişsel İnanışlar Ölçeği (SÜBÖ) 
 
Bu ölçek, kişilerin sigara içmeyle ilgili inançlarını belirlemek üzere geliştirilmiştir. Aşağıda insanların 
sigara içmeye dair ifade ettiği bazı inançlar sıralanmıştır. Önce, sigara içtiğiniz bir anı düşünmeye çalışın. 
Sonra her maddeyi okuyun ve bu ifadeye genellikle ne kadar katıldığınızı, uygun sayıyı işaretleyerek 
belirleyin. Lütfen bütün maddeleri işaretlemeye çalışın. Maddelerin herhangi bir doğru ya da yanlış cevabı 
yoktur. 







1. Sigara içmek daha net düşünmeme 
yardımcı olur. 
1 2 3 4 SÜBÖ-BDP 
2. Sigara içmek, huzursuz olduğumda 
rahatlamama yardımcı olur. 
1 2 3 4 SÜBÖ-DDP 
3. Sigara içmek irademin zayıf olduğunu 
gösterir. 
1 2 3 4 SÜBÖ-KEN 
4. Sigara içmekle ilgili böylesine çok 
düşünmek, bir şeyleri net bir şekilde 
anlamamı engeller. 
1 2 3 4 SÜBÖ-BEN 
5. Sigara içmek odaklanmama yardımcı 
olur. 
1 2 3 4 SÜBÖ-BDP 
6. Stresli olduğum zamanlarda, sigara 
içmek beni sakinleştirir. 
1 2 3 4 SÜBÖ-DDP 
7. Sigara içme isteğimi kontrol etmem 
zordur. 
1 2 3 4 SÜBÖ-KEN 
8. Sigara içmekle ilgili düşüncelerimi 
kontrol edemiyorum. 
1 2 3 4 SÜBÖ-BEN 
9. Sigara içmek düşüncelerimi düzene 
koymama yardımcı olur. 
1 2 3 4 SÜBÖ-BDP 
10. Sinirlendiğimde, sigara içmek beni 
yatıştırır. 
1 2 3 4 SÜBÖ-DDP 
11. Sigara içmem psikolojik anlamda 
zayıf olduğumu gösterir. 
1 2 3 4 SÜBÖ-KEN 
12. Sigara içmekle ilgili düşüncelerim bir 
takıntı haline geliyor. 
1 2 3 4 SÜBÖ-BEN 
13. Sigara içmek zihnimdekileri 
düzenlememe yardımcı olur. 
1 2 3 4 SÜBÖ-BDP 
14. Sigara içmek gevşememe yardımcı 
olur. 
1 2 3 4 SÜBÖ-DDP 
15. Kontrol edilmez bir şekilde sigara 
içiyorum. 
1 2 3 4 SÜBÖ-KEN 
16. Aklımın sürekli sigarada olması 
hayatımı yönetiyor. 
1 2 3 4 SÜBÖ-BEN 
17. Sigara içmek konsantre olmama 
yardımcı olur. 
1 2 3 4 SÜBÖ-BDP 
18. Sigara içmek baskı altında hissetmemi 
engeller. 
1 2 3 4 SÜBÖ-DDP 
19. Sigara içme dürtümü kontrol 
edemiyorum. 
1 2 3 4 SÜBÖ-KEN 





20. Sigarayla ilgili düşüncelerim 
hayatımın işleyişini bozuyor. 
1 2 3 4 SÜBÖ-BEN 
 
Note: SÜBÖ - BDP: Sigara İçmeyle ilgili Üstbilişsel İnanışlar Ölçeği-Bilişsel Düzenleme 
Hakkında Pozitif Üstbilişsel İnanışlar (1,5,9,13,17.maddeler), SÜBÖ - DDP: Sigara İçmeyle 
ilgili Üstbilişsel İnanışlar Ölçeği-Duygusal Düzenleme Hakkında Pozitif Üstbilişsel İnanışlar 
(2,6,10,14, maddeler), SÜBÖ -KEN: Sigara İçmeyle ilgili Üstbilişsel İnanışlar Ölçeği-
Sigaranın Kontrol Edilmezliği Hakkında Negatif Üstbilişsel İnanışlar (7,11,15,19.maddeler), 
SÜBÖ -BEN: Sigara içmeyle ilgili Üstbilişsel İnanışlar Ölçeği-Bilişsel Engellenme Hakkında 
Negatif Üstbilişsel İnanışlar (4,12,16,20. maddeler). 
 
  





Appendix: Metacognitions about Smoking Questionnaire (MSQ) 
This questionnaire is concerned with beliefs people hold about smoking. Listed below are a number of 
beliefs that people have expressed. First, try to think about when you smoke. Then, read each item and 
determine how much you generally agree with it by circling the appropriate number.  Please respond to all 
the items. There are no right or wrong answers. 
 











1. Smoking helps me think more clearly 1 2 3 4 PM-CR 
2. Smoking helps me to relax when I am 
agitated 
1 2 3 4 PM-ER 
3. Smoking means I have low will power 1 2 3 4 NM-U 
4. Thinking so much about smoking 
interferes with me seeing things 
clearly 
1 2 3 4 NM-CI 
5. Smoking helps me to focus my mind 1 2 3 4 PM-CR 
6. When I get stressed smoking calms 
me down 
1 2 3 4 PM-ER 
7. It is hard to control my desire for 
cigarettes 
1 2 3 4 NM-U 
8. I have lost control of my thoughts 
about smoking 
1 2 3 4 NM-CI 
9. Smoking helps me to order my 
thoughts 
1 2 3 4 PM-CR 
10. When I get upset smoking comforts 
me 
1 2 3 4 PM-ER 
11. My smoking means that I’m mentally 
weak 
1 2 3 4 NM-U 
12. My thoughts about smoking are 
becoming an obsession 
1 2 3 4 NM-CI 
13. Smoking helps me order things in my 
mind 
1 2 3 4 PM-CR 
14. Smoking helps me to unwind 1 2 3 4 PM-ER 
15. My smoking is uncontrollable 1 2 3 4 NM-U 
16. My preoccupation with cigarettes 
takes over my life 
1 2 3 4 NM-CI 
17. Smoking helps me concentrate 1 2 3 4 PM-CR 
18. Smoking distracts me from feeling 
pressured 
1 2 3 4 PM-ER 
19. I cannot control my urge to smoke 1 2 3 4 NM-U 
20. My thoughts about cigarettes interfere 
with my functioning 
1 2 3 4 NM-CI 
 
 






A confirmatory factor analysis supported the structure of the MSQ in a Turkish sample.  
Reliability and validity of the MSQ were observed to be good. 
Metacognitions predicted nicotine dependence independently of all other variables. 
 
 
 
 
 
